In Brief Anne-Marie Duliege named CMO of the Pancreatic Cancer Action Network February 26, 2021Vol.47 No.08
In Brief Fox Chase Cancer Center establishes Cancer Epigenetics Institute February 26, 2021Vol.47 No.08
In Brief Ryan Schoenfeld named chief scientific officer of The Mark Foundation for Cancer Research February 26, 2021Vol.47 No.08
Conversation with The Cancer Letter Kunle Odunsi: 50 years from now disparities—and metastatic disease—will be gone February 26, 2021Vol.47 No.08By Robert A. Winn
Drugs & Targets FDA approves Cosela to reduce bone marrow suppression caused by chemotherapy February 19, 2021Vol.47 No.07
Drugs & Targets Exact Sciences to acquire Ashion Analytics, enter research collaboration with City of Hope’s Genomics Institute, TGen February 19, 2021Vol.47 No.07
Clinical Roundup Study: Cabozantinib found to be most effective treatment for metastatic papillary kidney cancer February 19, 2021Vol.47 No.07
Clinical Roundup Gene-based blood test for melanoma spread evaluates treatment progress February 19, 2021Vol.47 No.07
Clinical Roundup JNCCN study: Weight loss associated with worse outcomes in people with HER2+ early breast cancer February 19, 2021Vol.47 No.07